Cargando…

Nasal alar metastasis of advanced hepatocellular carcinoma misdiagnosed as reactive cutaneous capillary endothelial proliferation in a patient treated with camrelizumab and apatinib: a case report

BACKGROUND: Reactive cutaneous capillary endothelial proliferation (RCCEP) is a common adverse event of camrelizumab in the treatment of advanced hepatocellular carcinoma. Facial skin metastasis is an exceptionally uncommon occurrence in hepatocellular carcinoma (HCC). It can be easily mistaken for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jin, Cao, Gang, Zhang, Genshan, Liu, Shuyi, Shi, Daqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331753/ https://www.ncbi.nlm.nih.gov/pubmed/37435210 http://dx.doi.org/10.21037/jgo-23-336

Ejemplares similares

Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation
por: Song, Geng, et al.
Publicado: (2022)

Reactive Cutaneous Capillary Endothelial Proliferation Caused by Camrelizumab: Sixteen Case Reports
por: Hui-Mei, Pang, et al.
Publicado: (2023)

Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report
por: Wu, Rui, et al.
Publicado: (2022)

Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation
por: Yin, Liang, et al.
Publicado: (2022)

Reactive cutaneous capillary endothelial proliferation predicted the efficacy of camrelizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma
por: Ding, Qi, et al.
Publicado: (2023)

A case report of thalidomide in the treatment of camrelizumab-induced reactive cutaneous capillary hyperplasia
por: Fu, Shujuan, et al.
Publicado: (2023)

Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial
por: Wang, Feng, et al.
Publicado: (2020)

Reconstruction of cutaneous defects of the nasal tip and alar by two different methods
por: Kim, Yong Hun, et al.
Publicado: (2018)

Emerging Treatments for Reactive Cutaneous Capillary Endothelial Proliferation
por: Liu, Yi, et al.
Publicado: (2023)

Skirt Flap for Nasal Alar Reconstruction
por: Ueda, Koichi, et al.
Publicado: (2014)

The Safety and Efficacy of Camrelizumab and Its Combination With Apatinib in Various Solid Cancers
por: Wang, Kunlun, et al.
Publicado: (2020)

Case report: A case of acute mastitis associated with reactive cutaneous capillary endothelial proliferation after camrelizumab treatment: A new immune-related adverse event
por: Wu, Ping-Shang, et al.
Publicado: (2022)

Inferiorly Based Alar Groove Flap for Correction of Alar Base Malposition and Nasal Stenosis
por: Patel, Niki, et al.
Publicado: (2022)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
por: Ju, Shuguang, et al.
Publicado: (2022)

A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
por: Yang, Qing, et al.
Publicado: (2023)

Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective Study
por: Wang, Jiaqiang, et al.
Publicado: (2021)

A Novel Technique for Nasal Alar Reconstruction
por: Nadjmi, Nasser, et al.
Publicado: (2022)

Nasal‐alar invasive cutaneous aspergillosis in a patient with anaplastic astrocytoma: A case report
por: Aljariri, Adham A., et al.
Publicado: (2021)

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
por: Huang, Julu, et al.
Publicado: (2023)

Microwave ablation combined with apatinib and camrelizumab in patients with advanced hepatocellular carcinoma: A single-arm, preliminary study
por: Li, Xin, et al.
Publicado: (2022)

Use of nasal packing as a splint for stabilizing nasal alar repairs
por: Dahak, Sabrina, et al.
Publicado: (2022)

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
por: Ju, Shuguang, et al.
Publicado: (2022)

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer
por: Wu, Yawen, et al.
Publicado: (2022)

Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol
por: Huang, Jun Tao, et al.
Publicado: (2023)

Outcome Study after Nasal Alar/Peri-alar Subunit Reconstruction: Comparing Paramedian Forehead Flap to Nasolabial Flap
por: Genova, Rafaella, et al.
Publicado: (2019)

Nasal alar rim redraping method to prevent alar retraction in rhinoplasty for Asian men: A retrospective case series
por: Choi, Jun Ho, et al.
Publicado: (2021)

Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer
por: Ye, Wei, et al.
Publicado: (2022)

Transcatheter arterial chemoembolization plus apatinib with or without camrelizumab for unresectable hepatocellular carcinoma: a multicenter retrospective cohort study
por: Duan, Xuhua, et al.
Publicado: (2023)

Rhinoplasty. The Difficult Nasal Tip: Total Resection of the Alar Cartilages
por: Rodriguez-Camps, Salvador
Publicado: (2008)

Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial
por: Ni, Jun, et al.
Publicado: (2023)

Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study
por: Zhu, Di, et al.
Publicado: (2022)

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma
por: Yang, Yonghao, et al.
Publicado: (2021)

Retracted: Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
por: Liu, Jieqiong, et al.
Publicado: (2020)

Large Auricular Chondrocutaneous Composite Graft for Nasal Alar and Columellar Reconstruction
por: Son, Daegu, et al.
Publicado: (2012)

Auricular Composite Chondrocutaneous Grafts in the Repair of Nasal Alar Rim Defects
por: Kim, Geon, et al.
Publicado: (2014)

Refinement of Nasal Reconstruction with a V/Y-alar-perforator Flap
por: Feinendegen, Dominik L., et al.
Publicado: (2017)

MRI and Additive Manufacturing of Nasal Alar Constructs for Patient-specific Reconstruction
por: Visscher, Dafydd O., et al.
Publicado: (2017)

Nasal reconstruction: Nasal Alar Rim Notching Deformity Reconstruction With Auricular Composite Chondrocutaneous Graft
por: Jackson, Spencer M., et al.
Publicado: (2018)

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study
por: Ding, Xi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8u97m2v0k55u42cl6749gshrd2